All posts by: Michael Zand

Momentum grows for hemophilia gene therapies | BioPharma Dive – BioPharma Dive

Investor’s Business DailyMomentum grows for hemophilia gene therapies | BioPharma DiveBioPharma DiveAn experimental gene therapy developed by BioMarin Pharmaceutical eliminated spontaneous bleeding and restored activity of a blood clotting protein to&n… Continue reading

Synthetic Biology Market 2025 with Focus on Emerging Technologies, Global Trends, Competitive Landscape … – Expert Consulting

TimeGazetteSynthetic Biology Market 2025 with Focus on Emerging Technologies, Global Trends, Competitive Landscape …Expert ConsultingSynthetic Biology Market – Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Compe… Continue reading

T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, Predicts Roots Analysis – Business Wire (press release)

Business Wire (press release)T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, Predicts Roots AnalysisBusiness Wire (press release)Pemba Lahmo, the principal analyst, stated, “With two approved therapies and over 480 clinical… Continue reading

Trial Results Are Positive For Two Rare Disease Gene Therapies – Pharmaceutical Processing

Trial Results Are Positive For Two Rare Disease Gene Therapies Pharmaceutical Processing To date, 11 patients have been dosed with a single intravenous injection of the ABO-102 gene therapy for systemic delivery of a functional copy of the missing SGSH gene associated with onset and progression of the disease. The SGSH gene provides … Explore the latest developments in ATMPs at SMi’s Cell & Gene Therapy 2018EIN News (press release) all 2 news articles »

FierceBiotech

Spark hemophilia B gene therapy clears test en route to Pfizer … FierceBiotech Spark Therapeutics has presented data on hemophilia B patients who received a version of its gene therapy manufactured using a modified process. Early data … Hunting a cure, Spark reports steady progress on hemophilia B …Endpoints News Spark’s gene therapy SPK-9001 shows treatment benefit in …Seeking Alpha Spark, Pfizer report progress on gene therapy for hemophiliaPhiladelphia Business Journal pharmaphorum –PMLiVE all 27 news articles »

Phys.Org

These CRISPR-modified crops don’t count as GMOs – Phys.org Phys.Org To feed the burgeoning human population, it is vital that the world figures out ways to boost food production. These CRISPR-modified crops don’t count as GMOs – San Francisco …San Francisco Chronicle all 2 news articles »

Scope (blog)

Recent Developments in the Stem Cell Market PR Newswire (press release) According to Grand View Research, Inc., the global stem cell market is projected to reach a value of USD 15.63 billion by 2025, while growing at a CAGR of 9.2%. The increasing number of research studies that aim at broadening the scope of stem cells … Where bioengineering and stem cell science meet, and thriveScope (blog) Stem Cell Treatment Aiding Cells After Heart AttackAnti Aging News Everything You Need to Know About Tarek El Moussa’s Controversial Stem Cell Treatment for His Back PainThe Cheat Sheet Korea Biomedical Review –Expert Consulting all 330 news articles »